One of the most innovative findings of our work is that three biomarkers that are also altered in neurological diseases (CD200R1, α2-MRAP, and MATN3) are among the strongest predictors of a negative outcome in the complete model. The gene discussed is LRPAP1; the disease is nervous system disorder.